After a higher open, it had a brief $1.00-plus retreat to $43.27 before continuing its move higher. The ensuing rally has taken the issue all the way to $46.94 but has not been able to hold that elevated level. That high comes in above its Aug. 17 high ($46.56) and just shy of its Aug. 16 high ($47.00).
The company made its all-time high in July at $50.90 just a few days after its Q1 beat on July 24, but swooned to $31.92 in August. The catalyst for that decline was when the company was targeted by Aurelius Value for exploiting the Opioid epidemic in America.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.